Search Results - "Casterás, A"

The role of diabetes duration, pubertal development and metabolic control in growth in children with type 1 diabetes mellitus by Luna, R, Alvarez-Vázquez, P, Hervás, E, Casterás, A, Pérez Méndez, L, Páramo, C, García-Mayor, R V

“…To investigate whether pubertal development, duration of type 1 diabetes mellitus (DM1), or metabolic control play some role in the anomalies in growth…”
Get more information

Malignant hypertension and pheochromocytoma: a case report by Bury, R, Leon Roman, J, Casteras, A, Vergara, A, Biagetti, B, García-Carro, C, Cordero-Vazquez, E, Hernández Hernández, I, Agraz, I, Soler, M J

“…Malignant arterial hypertension is defined by extremely high levels of pressure associated with organ damage. It is a cause of hypertensive emergency and is…”
Get more information

Long-term improvement of metabolic control without increased risk of hypoglycaemia by intensive insulin regimens in type 1 diabetes patients treated in a regular clinical setting by Pérez Méndez, L F, Alvarez-García, E, Alvarez-Vázquez, P, Hervás, E, Casterás, A, Fajar, L, García-Mayor, R V

“…To evaluate if intensive insulin regimen with multiple daily injections (MDI) is successful for treating type 1 diabetes patients over a long period of time in…”
Get more information

Pathophysiological features of neuroendocrine tumors in cyanotic congenital heart disease: a systematic review by Miranda Barrio, B, Rodrigo Toledo, R T, Anna Casteras, A C, Carlota Arenillas, C A, Antonia Pijuan, A P, Blanca Gordon, B G, Manel Maymi, M M, Victor Gonzalez, V G, Ignacio Ferreira, I F, Laura Dos, L D

Get full text

1178P Impact of comprehensive genomics profiling on treatment management of patients with advanced neuroendocrine neoplasms by Garcia-Alvarez, A., Hernando, J., Vivancos, A., Landolfi, S., Casteras, A., Simo, M., Burillo, A. Garcia, Blanco, L., Trejo, L., Garcia, M. Diez, Eyzaguirre, D.A. Acosta, Capdevila, J.

Get full text

1186P Impact of temozolomide (TEM) and capecitabine (CAP) dose reductions in toxicity and efficacy in patients (pts) with neuroendocrine neoplasms (NENs) treated with CAPTEM chemotherapy by Hernando, J., Garcia-Alvarez, A., Castaneda, D.H. Marmolejo, Eyzaguirre, D.A. Acosta, Garcia, M. Diez, Gonzalez, N. Saoudi, Casteras, A., Simo, M., Burillo, A. Garcia, Merino, X., Blanco, L., Sanchez, J.L., Roca, M., Capdevila, J.

Get full text

1381O - RNA expression profiles and splicing alterations in grade 1/2 neuroendocrine neoplasms from small intestine origin (siNENs). Final results of the GETNE-NETSEQ study by Capdevila, J., Castaño, J.P., Mancuso, F.M., Pedraza-Arevalo, S., Matos, I., Palmer, H.G., Salva, F., Landolfi, S., Jimenez-Fonseca, P., Garcia-Carbonero, R., Lopez, C., Ogbah, Z., Nuciforo, P.G., Casteras, A., Acosta, D., Diez, M., Hernando, J., Luque, R.M., Vivancos, A.

“…Despite favorable clinical and pathological prognostic factors, some patients (pts) with siNENs have impaired survival. In this study, we aimed to identify…”
Get full text

RNA expression profiles and splicing alterations in grade 1/2 neuroendocrine neoplasms from small intestine origin (siNENs). Final results of the GETNE-NETSEQ study by Capdevila, J., Castaño, J.P., Mancuso, F.M., Pedraza-Arevalo, S., Matos, I., Palmer, H.G., Salva, F., Landolfi, S., Jimenez-Fonseca, P., Garcia-Carbonero, R., Lopez, C., Ogbah, Z., Nuciforo, P.G., Casteras, A., Acosta, D., Diez, M., Hernando, J., Luque, R.M., Vivancos, A.

Get full text

1381ORNA expression profiles and splicing alterations in grade 1/2 neuroendocrine neoplasms from small intestine origin (siNENs). Final results of the GETNE-NETSEQ study by Capdevila, J, Castaño, J P, Mancuso, F M, Pedraza-Arevalo, S, Matos, I, Palmer, H G, Salva, F, Landolfi, S, Jimenez-Fonseca, P, Garcia-Carbonero, R, Lopez, C, Ogbah, Z, Nuciforo, P G, Casteras, A, Acosta, D, Diez, M, Hernando, J, Luque, R M, Vivancos, A

“…Abstract Background Despite favorable clinical and pathological prognostic factors, some patients (pts) with siNENs have impaired survival. In this study, we…”
Get full text

Differences in multikinase inhibitors (MKI) toxicity profile according to gender. A pooled analysis of three phase II trials with lenvatinib, pazopanib and sorafenib in patients (pts) with advanced gastroenteropancreatic (GEP) neuroendocrine tumours (NETs) by Hernando Cubero, J., Grande, E., Castellano Gauna, D., Ibrahim, T., Fazio, N., Lopez, C., Teulé, A., Valle, J.W., Alonso, V., Molina-Cerrillo, J., Tafuto, S., Custodio, A., Trejo, L., Casteras, A., Manneh Kopp, R., Miqueo, C., Roca Herrera, M., Garcia-Carbonero, R., Salazar, R., Capdevila, J.

Get full text

1387P - Differences in multikinase inhibitors (MKI) toxicity profile according to gender. A pooled analysis of three phase II trials with lenvatinib, pazopanib and sorafenib in patients (pts) with advanced gastroenteropancreatic (GEP) neuroendocrine tumours (NETs) by Hernando Cubero, J., Grande, E., Castellano Gauna, D., Ibrahim, T., Fazio, N., Lopez, C., Teulé, A., Valle, J.W., Alonso, V., Molina-Cerrillo, J., Tafuto, S., Custodio, A., Trejo, L., Casteras, A., Manneh Kopp, R., Miqueo, C., Roca Herrera, M., Garcia-Carbonero, R., Salazar, R., Capdevila, J.

“…There is a dearth of understanding of gender influence in targeted therapies toxicity. Increasing evidence suggests a possible different toxicity profile…”
Get full text

1387PDifferences in multikinase inhibitors (MKI) toxicity profile according to gender. A pooled analysis of three phase II trials with lenvatinib, pazopanib and sorafenib in patients (pts) with advanced gastroenteropancreatic (GEP) neuroendocrine tumours (NETs) by Hernando Cubero, J, Grande, E, Castellano Gauna, D, Ibrahim, T, Fazio, N, Lopez, C, Teulé, A, Valle, J W, Alonso, V, Molina-Cerrillo, J, Tafuto, S, Custodio, A, Trejo, L, Casteras, A, Manneh Kopp, R, Miqueo, C, Roca Herrera, M, Garcia-Carbonero, R, Salazar, R, Capdevila, J

“…Abstract Background There is a dearth of understanding of gender influence in targeted therapies toxicity. Increasing evidence suggests a possible different…”
Get full text

Different RNA expression profile defines prognosis in grade 1/2 neuroendocrine neoplasms of small intestine origin: The GETNE-NETSEQ study by Capdevila, J., Mancuso, F., Landolfi, S., Salva, F., Miguel, C., Jiménez-Fonseca, P., Garcia-Carbonero, R., López López, C., Casteras, A., Sauri Nadal, T., Nuciforo, P., Vivancos, A., Matos, I.

Get full text

Nutritional status of patients with advanced gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENS) in Spain: Nutrigetne study by Hernandez-Rienda, L., Casteras, A., Giribes, M., Antón, B., Librizzi, M.S., Custodio, A., Palma, S., Gutierrez, L. Suarez, Peiró, I., Urzaiz, L. Serrano, León-Idougourram, S., Felechosa, M. Dieguez, Febrero, B., Scorojanu, I., Toral, F. A. Pazos, Biarnes, J., Pascual-Corrales, E., Díaz-Pérez, J.A., Sampedro-Nuñez, M.A., Olmos, M. A. Martínez, Garcia, A. Mico, Del Olmo, M.I., Pla, M. Argente

Get full text

What to consider when pseudohypoparathyroidism is ruled out: iPPSD and differential diagnosis by Pereda, Arrate, Garin, Intza, Perez de Nanclares, Guiomar

“…Pseudohypoparathyroidism (PHP) is a rare disease whose phenotypic features are rather difficult to identify in some cases. Thus, although these patients may…”
Get full text

Hipertensión maligna y feocromocitoma: reporte de un caso by Bury, R., Leon Roman, J., Casteras, A., Vergara, A., Biagetti, B., García-Carro, C., Cordero-Vazquez, E., Hernández Hernández, I., Agraz, I., Soler, M.J.

“…La hipertensión arterial maligna se define por cifras extremadamente altas de presión arterial asociadas a daño orgánico. Constituye una causa de emergencia…”
Get full text

High percentage of adrenergic symptoms in extraadrenal chromaffin tumors by Hervás Abad, E, Páramo Fernández, C, Casteràs Román, A, Hernández De Alonso, E, Fajar Rodríguez, L, Ramírez Muñoz, L, García-Mayor, R V

“…Descriptive retrospective study of 14 patients with paragangliomas (PGL) attended in the University Hospital of Vigo (Pontevedra) during the last 25 years to…”
Get more information

Fascioliasis: una causa infrecuente de eosinofilia by Pérez Rodríguez, M. T., Fuente Aguado, J. de la, Pérez Fernández, S., Poderós Baeta, C., Samprón Rodríguez, M., Casteràs Román, A.

Get full text

Non-autoimmune adrenal failure: Addison's disease due to infiltration of adrenal glands of non-Hodgkin's lymphoma by Casteràs Román, A, Páramo Fernández, M C, Hervás Abad, E, Fajar Rodríguez, L, Mantiñán Gil, B, García-Mayor, R V

Get more information

Fascioliasis: an unusual cause of eosinophilia by Pérez Rodríguez, M T, de la Fuente Aguado, J, Pérez Fernández, S, Poderós Baeta, C, Samprón Rodríguez, M, Casteràs Román, A

Get full text